Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H34N6O8S |
InChIKeyJGNMGVDUZSRGNP-UZUCHZIWSA-N |
CAS Registry1020067-28-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 06 Mar 2006 |